Pain resolution and functional outcomes of total mesh excision: a case series.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 11 2022
accepted: 04 03 2023
medline: 19 9 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

The objective was to assess the impact of total excision of polypropylene midurethral slings (MUS) on patient pain levels and to report on functional outcomes including recurrent/de novo stress urinary incontinence (SUI), sexual function, and quality of life measures. This is a retrospective analysis of patients who underwent total MUS excision from March 2017 to December 2019. The primary outcome was the impact on pain assessed by a Numeric Rating Scale (NRS). Questionnaires analyzed were: Pain Catastrophizing Scale, Pelvic Floor Distress Inventory Short Form-20, Female Sexual Function Index, and McGill Pain Index questionnaires. Thirty-two women underwent total mesh excision within the inclusion period; with follow-up data available for 31 out of 32; 14 (43.8%) had previously undergone one or more partial vaginal mesh excision procedures. Types of MUS removed were: 14 (43.8%) transobturator midurethral slings, 12 (37.5%) retropubic midurethral slings, 4 (12.5%) mini-slings, and 2 (6.3%) mesh slings placed by laparotomy. Pain was the main reason for referral in 31 patients (96.9%). Mean pain NRS reduced from 6.1 pre-operatively to 3.3 post-operatively, with paired comparison showing a significant difference (p<0.01). Qualitatively, complete symptoms resolution was observed in 10 out of 31 (32.3%), another 9 out of 31 (29.0%) patients experienced clinically significant improvement, 2 out of 31 (6.5%) did not experience improvement in pain, and 10 out of 31 (32.3%) reported new/worsening pain. Post-operative complications occurred in 9 (29.0%) patients; all were Clavien-Dindo grade II. Nineteen (61.3%) reported de novo/recurrent SUI post-operatively. Total MUS mesh excision yields high complication and SUI recurrence rates, counter-balanced by a 61.3% pain resolution/improvement rate. These data are pertinent for patient counseling.

Identifiants

pubmed: 37004520
doi: 10.1007/s00192-023-05516-2
pii: 10.1007/s00192-023-05516-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2115-2123

Informations de copyright

© 2023. The International Urogynecological Association.

Références

Abbott S, Unger C, Evans J, et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicentre study. Am J Obstet Gynecol. 2014;210(2):163–8.
doi: 10.1016/j.ajog.2013.10.012
Rice N, Hu Y, Slaughter J, Ward R. Pelvic mesh complications in women before and after the 2011 FDA public health notification. Female Pelvic Med Reconstr Surg. 2013;19(6):333–8.
doi: 10.1097/SPV.0b013e3182a330c1 pubmed: 24165446
Vervest H, Bongers M, van der Wurff A. Nerve injury: an exceptional cause of pain after TVT. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(6):665–7.
doi: 10.1007/s00192-005-0034-1 pubmed: 16633884
Unger C, Rizzo A, Ridgeway B. Indications and risk factors for midurethral sling revision. Int Urogynecol J. 2016;27:117–22.
doi: 10.1007/s00192-015-2769-7 pubmed: 26134541
Rardin CR, Duckett J, Milani AL, et al. Joint position statement on the management of mesh-related complications for the FPMRS specialist. Int Urogynecol J. 2020;31(4):679–94. https://doi.org/10.1007/s00192-020-04248-x
doi: 10.1007/s00192-020-04248-x
Farrar JT, Young JJ, LaMoreaux L, Werth J, Poole M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–58.
doi: 10.1016/S0304-3959(01)00349-9 pubmed: 11690728
Davis T, Loudermilk E, DePalma M, Hunter C, Lindley D, Patel N. Prospective, multicenter, randomized, crossover clinical trial comparing the safety and effectiveness of cooled radiofrequency ablation with corticosteroid injection in the management of knee pain from osteoarthritis. Reg Anesth Pain Med. 2018;43(1):84–91.
doi: 10.1097/AAP.0000000000000690 pubmed: 29095245
Haylen B, de Ridder D, Freeman R, Swift SE, Berghmans B, Lee J et al. An international urogynecological association (IUGA)/International continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26.
Chinthakanan O, Miklos J, Moore R, Karp D, Noqueiras G, Davila G. The indication and surgical treatment of 286 midurethral synthetic sling complications: a multicenter study. Surg Technol Int. 2016;26(29):167–71.
Hou J, Alhalabi F, Lemack G, et al. Outcome of transvaginal mesh and tape removed for pain only. J Urol. 2014;192(3):856–60.
doi: 10.1016/j.juro.2014.04.006 pubmed: 24735934
Jambusaria L, Heft J, Reynolds W, Dmochowski R, Biller D. Incontinence rates after midurethral sling revision for vaginal exposure or pain. Am J Obstet Gynecol. 2016;215(6):764.
doi: 10.1016/j.ajog.2016.07.031
Shawer S, Boodhoo V, Licari O, et al. Total trans-obturator tape (TOT) removal; a case series including pain and urinary continence outcomes. Int Urogynecol J. 2022;7:1–7.
Cardenas-Trowers O, Malekzadeh P, Nix D, Hatch K. Vaginal mesh removal outcomes: eight years of experience at an academic hospital. Female Pelvic Med Reconstr Surg. 2017;23:382–6.
doi: 10.1097/SPV.0000000000000419 pubmed: 28430726
Misrai V, Rouprêt M, Xylinas E, et al. Surgical resection for suburethral sling complications after treatment for stress urinary incontinence. J Urol. 2009;181:2198–203.
doi: 10.1016/j.juro.2009.01.036 pubmed: 19296973
Fabian G, Kociszewski J, Kuszka A, et al. Vaginal excision of the sub-urethral sling: analysis of indications, safety and outcome. Arch Med Sci. 2015;11:982–8.
pubmed: 26528340 pmcid: 4624732
Ramart P, Ackerman A, Cohen S, Kim J, Raz S. The risk of recurrent urinary incontinence requiring surgery after suburethral sling removal for mesh complications. Urology. 2017;106:203–9.
doi: 10.1016/j.urology.2017.01.060 pubmed: 28476681
Rigaud J, Pothin P, Labat J, et al. Functional results after tape removal for chronic pelvic pain following tension-free vaginal tape or transobturator tape. J Urol. 2010;184(2):610–5.
doi: 10.1016/j.juro.2010.03.132 pubmed: 20639025
Marcus-Braun N, Bourret A, von Theobald P. Persistent pelvic pain following transvaginal mesh surgery: a cause for mesh removal. Eur J Obstet Gynecol. 2012;162:224–8.
doi: 10.1016/j.ejogrb.2012.03.002
Agnew G, Dwyer P, Rosamilia A, Lim Y, Edwards G, Lee J. Functional outcomes following surgical management of pain, exposure or extrusion following a suburethral tape insertion for urinary stress incontinence. Int Urogynecol J. 2014;25(2):235–9.
doi: 10.1007/s00192-013-2207-7 pubmed: 24005442
Selçuk I, Bozdağ G. Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature. J Turk Ger Gynecol Assoc. 2013;14(2):98–103.
doi: 10.5152/jtgga.2013.52385 pubmed: 24592083 pmcid: 3881735
Vercellini P, Barbara G, Abbiati A, Somigliana E, Viganò P, Fedele L. Repetitive surgery for recurrent symptomatic endometriosis: what to do? Eur J Obstet Gynecol Reprod Biol. 2009;146(1):15–21.
doi: 10.1016/j.ejogrb.2009.05.007 pubmed: 19482404
George AMD, Mattingly MMD, Woodman PDO, Hale DMD. Recurrence of prolapse after transvaginal mesh excision. Female Pelvic Med Reconstr Surg. 2013;19:202–5.
doi: 10.1097/SPV.0b013e31829098a5 pubmed: 23797517

Auteurs

Breffini Anglim (B)

Division of Female Pelvic Medicine and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, 700 University Avenue, Room 8-917, Mount Sinai Hospital, Toronto, Ontario, Canada. breffini.anglim@gmail.com.

Zi Ying Zhao (ZY)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Shruti Parshad (S)

Division of Female Pelvic Medicine and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, 700 University Avenue, Room 8-917, Mount Sinai Hospital, Toronto, Ontario, Canada.

John Matelski (J)

Division of Female Pelvic Medicine and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, 700 University Avenue, Room 8-917, Mount Sinai Hospital, Toronto, Ontario, Canada.

Nucelio Lemos (N)

Division of Female Pelvic Medicine and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, 700 University Avenue, Room 8-917, Mount Sinai Hospital, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH